Obesity Connect
Profile Image
Add Media
  • Saved

3w
Rethinking LPCAT3 roles in human disease: broadening perspectives beyond ferroptosis. - PubMed

Rethinking LPCAT3 roles in human disease: broadening perspectives beyond ferroptosis. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42399667

Discover LPCAT3's role in phospholipid remodeling and its impact on diabetes and NAFLD, relevant to primary care.


LPCAT3 remodels phospholipids, impacting autophagy, endoplasmic reticulum homeostasis, and inflammation, relevant to diabetes and NAFLD in primary care.

Profile Image
  • Uploads
  • Saved

1mo
Study protocol for a 15-year follow-up of a randomized controlled trial on lifestyle intervention in pregnancy: assessing long-term effects on body composition, metabolic traits, and mental health in mothers and offspring. - PubMed

Study protocol for a 15-year follow-up of a randomized controlled trial on lifestyle intervention in pregnancy: assessing long-term effects on body composition, metabolic traits, and mental health in mothers and offspring. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41535891

Explore the 15-year impact of maternal lifestyle interventions during pregnancy on childhood obesity using DXA scans and glucose monitoring in a follow-up trial.


The study examines long-term effects of pregnancy lifestyle interventions on offspring using DXA scans and glucose monitoring in a follow-up of a randomized controlled trial.

Profile Image
  • Uploads
  • Saved

1mo

In patients with obesity and cardiometabolic comorbidities, what most shapes your management intensity?

  • Uploads
  • Saved

1mo
A Healthy Diet Intervention Alters Food Preferences and Eating Behaviours Without Changing Appetite, Adipokines or Glucose Homoeostasis. - PubMed

A Healthy Diet Intervention Alters Food Preferences and Eating Behaviours Without Changing Appetite, Adipokines or Glucose Homoeostasis. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42318824

Discover how a 12-week Mediterranean diet affects food preferences and eating behaviors without impacting appetite or metabolic markers in individuals at metabolic risk.


A Mediterranean diet intervention significantly reduced uncontrolled eating (p=0.0226) and increased cognitive restraint (p=0.0004) without altering metabolic markers.

Profile Image
  • Uploads
  • Saved

1mo
DDW 2026 highlights colorectal cancer screening, GLP-1 research, and Crohn’s disease therapy

Asma Shaukat, MD, Professor of Medicine at NYU Grossman School of Medicine and outgoing Chair of the Clinical Practice Section for the AGA Council, discussed 13-year Nordic trial findings showing reduced colorectal cancer incidence with colonoscopy screening, along with emerging data on GLP-1 therapies in fatty liver disease and cirrhosis. Bruce Sands, MD, Chief of Gastroenterology and Professor of Medicine at the Icahn School of Medicine at Mount Sinai, presented findings from the DUET-CD study evaluating combination therapy in Crohn’s disease.

Profile Image
  • Uploads